7447 Nagaileben
- 2303
- -25-1.07%
Nagaileben News
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1814＞ Daisue Ken 1756 1849 ＜1949＞ Sumitomo Densetsu 3475 3890 ＜2198＞ IKK 756 773 ＜2384＞ SBSHD 2569 2755 ＜2692＞ ITOCHU Food 7
List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○List of unscathed stocks market code stock name closing price advance span A advance span B Tokyo stock prime ＜1887＞ Japan Land Development 520 523 565.5 ＜1899＞ Fukuda Gumi 5350 5580 5445 ＜2282＞ Nichi-Ham 5085 5212.25 5091.5 ＜2327＞
Express News | Nagaileben Co Ltd - Announces Result of Share Buyback for April 3-30
List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]
○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜2211＞ Fujiya 2487 2479 2483.5 ＜2502＞ Asahi 5428 5357.5 5415.5 ＜6268＞ Nabtesco 2842 2526 2642 ＜6315＞ TOWA 9
Nagairebe Research Memo (10): Pledged a dividend payout ratio of 50% or more (on a standalone basis), and the annual dividend is expected to be 60.0 yen
■Shareholder Return Measures The equity ratio of Nagai Leven ＜7447＞ is as high as 91.2% (end of the fiscal year ending 2023/8), and financial details are stable. Furthermore, considering the company's business type, profits are unlikely to deteriorate rapidly, and earnings stability is expected to continue. As a result of these, when external allocations (shareholder returns) are low, profits retained each year will accumulate into equity capital, and the net return on equity (ROE) will decline, in other words, capital efficiency will decline
Nagailebe Research Memo (9): The medium-term management plan aims for an operating profit of 5.5 billion yen for the fiscal year ending 2026/8
Nagai Leven ＜7447＞ has announced a medium-term management plan that rolls over plans up to that point based on results for the 2023/8 fiscal year, but there are currently no changes to these plans.
Nagailebe Research Memo (7): Financial details are solid, cash and deposits on hand are at a high level of 25 billion yen
■Performance Trends 2. Financial Situation The financial situation of Nagai Leven ＜7447＞ continues to be stable. Total assets at the end of the second quarter of the 2024/8 fiscal year ended were 45,577 million yen, a decrease of 1,799 million yen from the end of the previous fiscal year. Current assets decreased by 1,765 million yen to 37,229 million yen, but the main factors were a decrease of 2,097 million yen in cash and deposits, a decrease of 77 million yen in notes receivable and accounts receivable, including electronic record receivables, and an increase of 942 million yen in inventory assets. On the other hand, fixed capital
Nagailebe Research Memo (4): Focus on expanding sales of highly functional products with high added value (2)
■Business Overview 4. Corporate Policy (CSR Initiatives) Nagai Leven (7447) celebrated its 100th anniversary in 2015, and during this time, it has fostered a corporate spirit called “Nagaism,” which is centered on the three elements of “human harmony,” “profit generation,” and “contribution to society.” Since then, we have continued to work on CSR by implementing the following measures. [Main Initiatives Centered on “I Want to Help Life”] (1) Women's Empowerment: Supporting Industries Where Women Lead the Role Most of the Company's Products Are Illnesses
Nagailebe Research Memo (2): Top manufacturer of medical white coats with a domestic market share of over 60% in the core market
■Company Overview Nagaileben ＜7447＞ is a specialized manufacturer of medical white coats for nurses, doctors, patients, etc. It has a long history, and it was founded as “Nagai Shoten” in 1915. After that, the business expanded nationwide, and according to the company, it now has a domestic market share of over 60% in the medical white coat core market* centered on nurses, and is a top manufacturer of medical white coats supplying 6.5 million pieces per year. Also, due to the reorganization of the Tokyo Stock Exchange market division in April 2022, Prime Market
Nagai Rebe--- Operating profit decreased by 13.5% compared to the same period last year in the second quarter of the fiscal year ending 2024/8, and the gross margin ratio improved
Nagai Leven's consolidated financial results for the second quarter of the fiscal year ending 2024/8 [7447] were sales down 6.8% from the same period last year to 7,392 million yen, operating profit down 13.5% to 1,608 million yen, ordinary profit down 13.3% to 1,639 million yen, and quarterly net profit attributable to parent company shareholders down 12.9% to 1,129 million yen. While medical fees are constant at medical institutions, various prices have risen due to inflation, etc., so the tough business environment continues.
Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜5821＞ Hirakawa Hute 1296 1329 ＜5943＞ Noritz 1741 1785 ＜5949＞ Unipres 1126 1187 ＜6099＞ Elan 880 954 ＜6143＞ Sodick
Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]
○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1515＞ Nittetsu Mining 5070 4765 ＜1663＞ K&O Energy 3270 2853 ＜1934＞ Yourtech 1480 1381 ＜1939＞ Yodenko 3920 3725 ＜1982＞ Hibiya Setsu 2965 2759 ＜2288＞
List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]
○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1820＞ Nishimatsuken 4412 4383.5 4192.5 ＜1878＞ Daitoken 17130 16911.25 16682.5 ＜1925＞ Daiwa House 4429 4398.5 4385 ＜2060＞ Fee
Nagai Rebe--even though sales declined in 2Q, gross profit margin improved due to an increase in overseas production rates and sales price revisions
Nagai Leven ＜7447＞ announced consolidated financial results for the 2nd quarter (23/9/24 to 2/24) of the fiscal year ending 2024/8 on the 2nd. Sales decreased 6.8% from the same period last year to 7.392 billion yen, operating profit fell 13.5% to 1,608 billion yen, ordinary profit fell 13.3% to 1,639 billion yen, and quarterly net profit attributable to parent company shareholders fell 12.9% to 1,129 billion yen. The Group's sales during the 2nd quarter cumulative period were due to rush demand before product price revisions in the same period last year
4/3 [Today's Investment Strategy]
[FISCO Specially Selected Brand] [Material Brand] Sugi Holdings＜7649＞ 2505.5 yen (4/2) will develop the drugstore “Sugi Pharmacy.” Financial results for the fiscal year ending February 24 have been announced. Operating profit was 36.6 billion yen (up 15.7% from the previous fiscal year). The operating profit forecast for the fiscal year ending 24/2 was raised by about 4% from the previous forecast on 3/26. Operating profit for the fiscal year ending 25/2 is expected to be 40 billion yen (up 9.2% from the previous fiscal year). Transfer of physical tasks to medical offices, education and training for pharmacists, thorough use of digital technology, medicine
Pay attention to Sugi HD and V-Cube
On the US stock market yesterday 2nd, the NY Dow depreciated by 396.61 dollars to 39170.24, the Nasdaq Composite Index fell 156.38 points to 16240.45, and the Chicago Nikkei 225 futures were 39670 yen lower than the Osaka Japan-China ratio. The exchange rate is 1 dollar = 151.50-60 yen. In today's Tokyo market, Sugi HD (7649) and Joshin Denki (8173), which announced that operating profit is expected to increase 15.7% for the previous fiscal year and 9.2% increase for the current fiscal year, announced that they have adopted video manual posting and viewing platforms
Company stock buybacks announced on 4/2, such as OBARA-G
The stocks that announced their share acquisition quota settings on 4/2 (Tuesday) are as follows ＜6877＞OBARA-G 2.15 million shares (12.1%) 7,521 million yen (24/4/3-25/3/24) ＜7447＞Nagailebe 500,000 shares (1.6%) 1 billion yen (24/4/3-24/9/30) *% of the number of shares () is the ratio of the total number of issued shares (excluding treasury shares) ※The upper limit of the number of shares and amount
Sugi HD, 24/2 full year operating profit 15.7% up 36.6 billion yen, 25/2 forecast 9.2% increase 40 billion yen
The financial results for the fiscal year ending 2024/2 announced by Sugi HD ＜7649＞ were sales of 744.477 billion yen, up 11.5% from the previous fiscal year, and operating profit of 36.622 billion yen, up 15.7% from the same period. As for the financial results for the fiscal year ending 2025/2, we plan that sales will increase 8.8% from the previous fiscal year to 810 billion yen, and operating profit will increase 9.2% to 40 billion yen. In addition to actively opening new stores to capture customer demand, cost reductions will contribute through promotion of DX), etc. [Positive Evaluation] ＜7649＞Sugi HD
Nagaileben Sees FY Net Y3.08B
Nagaileben Co. Ltd. also released the following forecasts: GROUP Year Ending Aug 2024 Revenue Y17.20 bln Operating Profit Y4.40 bln Pretax Profit
Kasumigaseki Capital, Nagairebe, Sugi HD, Okuwa (2 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/2 (Tue) ＜3498＞Kasumigaseki Capital ＜7447＞Nagai Rebe ＜7649＞Sugi HD ＜8217＞Okuwa-----------------------4/3 (Wed) ＜1376＞Kaneko Seedlings
Analysis
Price Target
No Data
